Methods of efficiently establishing induced pluripotent stem cells under hypoxic conditions
Provided is a method of improving the efficiency of establishment of induced pluripotent stem cells, comprising culturing somatic cells under hypoxic conditions in the step of nuclear reprogramming thereof.
1. A method of improving the efficiency of establishment of mouse or human induced pluripotent stem (iPS) cells, comprising:
a) introducing into mouse or human somatic cells an expression vector or expression vector expression vectors comprising nucleic acids encoding any of the following (i) to (ii):
(i) Oct3/4, Klf4 and Sox2,
(ii) Oct3/4, Klf4, Sox2 and c-Myc, and
b) culturing the somatic cells from a) in ES cell culture medium, under hypoxic conditions wherein the oxygen concentration is 5%,
thereby improving the efficiency of the establishment of iPS cells compared to the establishment efficiency of mouse or human iPS cells produced by the same method at an atmospheric concentration of oxygen.
2. The method according to claim 1 , comprising the further step that valproic acid is used to improve the efficiency.
3. The method according to claim 1 , wherein culturing somatic cells under hypoxic conditions is performed for more than 3 days after introducing the expression vector or vectors into the somatic cells.
4. The method according to claim 1 wherein the iPS cell is a mouse iPS cell.
5. The method according to claim 1 wherein the iPS cell is a human iPS cell.
6. The method according to claim 1 wherein the mouse or human somatic cells are fibroblasts.
7. A method of producing a mouse or human induced pluripotent stem (iPS) cell, comprising:
a) introducing into mouse or human somatic cells an expression vector or expression vectors comprising nucleic acids encoding any of the following (i) to (ii):
(i) Oct3/4, Klf4 and Sox2,
(ii) Oct3/4, Klf4, Sox2 and c-Myc, and
b) culturing the somatic cells from a) in ES cell culture medium, under hypoxic conditions wherein the oxygen concentration is 5%,
thereby producing a mouse or human iPS cell, wherein the efficiency of producing said mouse or human iPS cells is improved compared to the production efficiency of a mouse or human iPS cell produced by the same method at an atmospheric concentration of oxygen.
8. The method according to claim 7 , comprising the further step that said somatic cell is contacted with valproic acid.
9. The method according to claim 7 , wherein culturing somatic cells under hypoxic conditions is performed for more than 3 days after introducing the expression vector or vectors into the somatic cells.
10. The method according to claim 7 , wherein the iPS cell is a mouse iPS cell.
11. The method according to claim 7 , wherein the iPS cell is a human iPS cell.
12. The method according to claim 7 , wherein the somatic cell is a fibroblast.
13. A method for improving the efficiency of establishment of mouse induced pluripotent stem (iPS) cells, comprising:
a) introducing into mouse somatic cells an expression vector or expression vectors comprising nucleic acids encoding any of the following (i) to (iv):
(i) Oct3/4, Klf4 and Sox2,
(ii) Oct3/4, Klf4, Sox2 and c-Myc,
(iii) Oct3/4 and Klf4,
(iv) Oct3/4 and c-Myc, and
b) culturing the somatic cells from a) in ES cell culture medium, under hypoxic conditions, wherein the oxygen concentration is 1-5%,
thereby improving the efficiency of the establishment of iPS cells compared to the efficiency of establishment of mouse iPS cells produced by the same method at an atmospheric concentration of oxygen.
14. A method of improving the efficiency of establishment of reprogrammed mouse or human cells, comprising:
a) introducing into mouse or human somatic cells an expression vector or expression vectors comprising nucleic acids encoding any of the following (i) to (ii):
(i) Oct3/4, Klf4 and Sox2,
(ii) Oct3/4, Klf4, Sox2 and c-Myc, and
b) culturing the somatic cells from a) in ES cell culture medium, under hypoxic conditions wherein the oxygen concentration is 5%,
thereby improving the efficiency of the establishment of reprogrammed mouse or human cells compared to the efficiency of establishment of reprogrammed mouse or human cells produced by the same method at an atmospheric oxygen concentration, and
wherein the reprogrammed mouse or human cells form ES-like colonies and are in a more undifferentiated state than the mouse or human somatic cells.